Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.32 -3.03

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.32

Maximum

0.33

Fő mutatók

By Trading Economics

Bevétel

2.6M

-5.5M

Értékesítés

3M

38M

Egy részvényre jutó nyereség

-0.03

Profit margin

-14.573

Munkavállalók

128

EBITDA

2.1M

-5.5M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-36M

61M

Előző nyitás

3.35

Előző zárás

0.32

Hangulat hírek alapján

By Acuity

46%

54%

114 / 340 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 28. 23:56 UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

2026. aug. 28. 23:46 UTC

News

Diamondback Energy shares declined after-market, despite earlier gains, amid rising market expectations for a rate hike and increased Treasury yields.

2026. aug. 28. 23:46 UTC

News

Target Corp filed for a mixed securities shelf and registered 15.5 million shares under its employee incentive plan. Shares remained roughly flat in after-market hours.

2026. aug. 28. 23:41 UTC

News

Blue Owl Capital gained in after-market trading after leading a $2.4 billion financing deal for Iren Ltd. to purchase Nvidia Blackwell Ultra GPUs.

2026. aug. 28. 23:41 UTC

News

Group 1 Automotive Inc shares declined in after-market hours, pressured by ratings downgrades from Barclays PLC and Weiss Ratings amid rising Treasury yields.

2026. aug. 28. 23:21 UTC

News

Incyte Corp shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down amid rising Treasury yields and mixed ESMO data sentiment.

2026. aug. 28. 23:21 UTC

News

Intuit Inc. shares are trading lower in after-market hours following a class action lawsuit alleging misleading statements about its financial performance and competitive advantages.

2026. aug. 28. 23:06 UTC

News

Coherus Oncology's $50 million common share offering pressures shares lower in after-market trading, marking a pullback from recent highs.

2026. aug. 28. 23:06 UTC

News

BioNTech SE shares are higher in after-market trading, supported by a Strong Buy rating and a cash position of $19.28 billion for R&D efforts.

2026. aug. 28. 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate expectations and geopolitical tensions impact investor confidence.

2026. aug. 28. 23:06 UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate hike expectations and geopolitical tensions impact market confidence.

2026. aug. 28. 23:06 UTC

News

Lowe's Companies declared a quarterly cash dividend of $1.25 per share, boosting shares in after-market trading following the announcement.

2026. aug. 28. 23:06 UTC

News

Visa Inc shares are higher in after-market trading following a partnership with Dunamu to develop stablecoin payments and cross-border remittance services.

2026. aug. 28. 23:06 UTC

News

Michael Burry has reduced his stake in PayPal as acquisition talks with Advent International and Stripe have ended. Shares are slightly higher in after-hours trading.

2026. aug. 28. 23:02 UTC

News

Halliburton Co is positioned for multi-billion-dollar deals in Venezuelan crude reserves, contributing to higher shares in after-market hours.

2026. aug. 28. 23:01 UTC

News

Pinterest Inc shares declined in after-market trading following the resignation announcement of CFO Julia Brau Donnelly, effective October 30, 2026. Trading remains weak overall.

2026. aug. 28. 23:01 UTC

News

Chemours Co faces an investigation by Pomerantz LLP over potential securities law violations. Shares are trading higher in after-market hours despite concerns over internal controls.

2026. aug. 28. 23:01 UTC

News

Alnylam Pharmaceuticals shares rose in after-market hours, despite concerns from a failed cardiomyopathy trial. The company's market capitalization stands at $31.57 billion.

2026. aug. 28. 23:01 UTC

News

Flowers Foods shares are lower in after-market trading following the filing of a mixed securities shelf, raising potential concerns about dilution and financial strategy.

2026. aug. 28. 23:01 UTC

Event
News

Eli Lilly's shares rise in after-market trading following FDA approval of Mounjaro for reducing cardiovascular risks in type 2 diabetes patients.

2026. aug. 28. 23:01 UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, targeting two heavy-oil fields. Shares are trading higher in after-market hours.

2026. aug. 28. 23:01 UTC

News

McKesson Corp disclosed a cybersecurity incident affecting its information systems, with shares trading lower in after-market hours amid broader market weakness.

2026. aug. 28. 23:01 UTC

News

Vistra Corp reported gross revenue of $17.74 billion and net income of $944 million. Shares are higher in after-market trading following the earnings release.

2026. aug. 28. 23:01 UTC

News

Planet Fitness Inc shares declined in after-market trading following a class action lawsuit alleging misleading investor information about customer metrics and reduced growth guidance.

2026. aug. 28. 21:01 UTC

News

Hyatt Hotels filed a mixed shelf registration, seen as potentially dilutive. Shares are trading lower in after-market hours, continuing a recent decline.

2026. aug. 28. 20:52 UTC

News
Correlated Moves

Silver prices are declining amid negative sentiment in precious metals. Remarks from Federal Reserve Chair Warsh and weak consumer sentiment contribute to the drop.

2026. aug. 28. 20:52 UTC

Correlated Moves
News

Silver/JPY is trading lower amid negative sentiment in precious metals following Federal Reserve comments on potential rate increases and a decline in consumer sentiment.

2026. aug. 28. 20:52 UTC

Correlated Moves
News

Silver is trading lower as negative sentiment in precious metals grows after comments from Federal Reserve Chair Kevin Warsh regarding potential rate increases.

2026. aug. 28. 20:52 UTC

Correlated Moves
News

Silver Ounce vs Euro is lower amid negative sentiment in precious metals following Federal Reserve remarks and a significant decline in the Michigan Consumer Sentiment index.

2026. aug. 28. 20:52 UTC

Correlated Moves
News

Silver prices are lower amid negative sentiment from Federal Reserve remarks and a decline in the Michigan Consumer Sentiment index. The asset remains volatile.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Értékelési konszenzus

By TipRanks

Semleges

2 ratings

0

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

114 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat